60 DEGREES PHARMA INC (SXTP) Earnings History & Surprises
NASDAQ:SXTP • US83006G5009
2.05 USD
-0.01 (-0.49%)
At close: Mar 6, 2026
2.01 USD
-0.04 (-1.95%)
Pre-Market: 3/9/2026, 4:44:36 AM
Past quarterly earnings results for 60 DEGREES PHARMA INC (SXTP), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Release DateN/A
PeriodQ4 / 2025
EPS Estimate-$2.33
Revenue Estimate545.7K
Last Reported
Release DateNov 13, 2025
PeriodQ3 / 2025
EPS Reported-$2.64
EPS Surprise 46.52%
Revenue Surprise 29.55%
Beat Rate
25%
EPS and Revenuebeats vs estimates
Quarterly Earnings Results
EPS & Revenue History (USD)
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | -2.64 | -4.94 | 46.52% | 43.23% | 528.56K | 408K | 29.55% | 291.53% |
| Q2 2025 | -5.00 | -3.92 | -27.66% | 76.36% | 307.87K | 307.02K | 0.28% | 146.30% |
| Q1 2025 | -1.56 | -1.34 | -16.31% | -186.67% | 163K | 231.54K | -29.60% | 11.58% |
| Q4 2024 | -14.20 | -4.09 | -247.17% | 34.26% | 231K | 238.68K | -3.22% | 440.86% |
| Q3 2024 | -4.65 | -3.60 | -29.33% | -110.06% | 135K | 246.84K | -45.31% | 164.71% |
| Q2 2024 | -21.15 | -14.25 | -48.37% | - | 125K | 215.73K | -42.06% | 99.36% |
| Q1 2024 | 1.80 | -9.18 | 119.61% | - | 146.09K | 164.22K | -11.04% | 579.49% |
| Q4 2023 | -21.60 | -12.55 | -72.17% | - | 42.71K | 76.5K | -44.17% | -91.65% |
| Q3 2023 | 46.20 | 58.14 | -20.54% | - | 51K | 89.25K | -42.86% | -90.87% |
| Q2 2023 | - | - | 62.7K | - | - | |||
| Q1 2023 | - | - | 21.5K | - | - | |||
| Q4 2022 | - | - | 511.2K | - | - | |||
| Q3 2022 | - | - | 558.5K | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
1
Average EPS beat (4)
-61.15%
Max EPS beat (4)
46.52%
Min EPS beat (4)
-247.17%
Revenue beat statistics
Revenue beat (4)
2
Average Revenue beat (4)
-0.75%
Max Revenue beat (4)
29.55%
Min Revenue beat (4)
-29.60%
Analysis
In the last 4 quarters, SXTP has beaten EPS estimates in 1 out of 4 releases
SXTP has beaten revenue estimates in 2 out of the last 4 releases
In the last 4 quarters, SXTP reported -61.2% below the EPS estimates on average.
In the last 4 quarters, SXTP reported -0.7% below the revenue estimates on average.
60 DEGREES PHARMA INC / SXTP Earnings FAQ
What is the most recent earnings date for SXTP stock?
60 DEGREES PHARMA INC (SXTP) last reported earnings on 11/13/2025.
Did 60 DEGREES PHARMA INC (SXTP) beat earnings estimates last quarter?
60 DEGREES PHARMA INC (SXTP) beat EPS estimates and beat revenue estimates in the most recent quarter.
What percentage of the time does SXTP stock beat earnings estimates?
In the last 4 quarters, 60 DEGREES PHARMA INC (SXTP) has beaten EPS estimates in 1 out of 4 releases.